AFTING ERNST-GUENTER
Insider CIK 1234864 · SQNM Director · ENTA Director · SRNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2015-02-19 | 2015-02-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2014-02-06 | 2014-02-10 | 4,640 | — | $0 | 4,640 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2013-12-11 | 2013-12-13 | 2,100 | $37.92 | $79.6K | 17,287 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2013-12-11 | 2013-12-13 | 5,800 | $36.38 | $211.0K | 26,487 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2013-12-11 | 2013-12-13 | 7,100 | $37.20 | $264.1K | 19,387 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 9,000 | — | $0 | 26,600 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-06-11 | 2013-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion deriv | 2013-03-26 | 2013-03-28 | 48,337 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion deriv | 2013-03-26 | 2013-03-28 | 10,000 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion deriv | 2013-03-26 | 2013-03-28 | 10,000 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion deriv | 2013-03-26 | 2013-03-28 | 320 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion deriv | 2013-03-26 | 2013-03-28 | 2,906 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion | 2013-03-26 | 2013-03-28 | 97 | — | $0 | 21,072 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion | 2013-03-26 | 2013-03-28 | 11,215 | — | $0 | 32,287 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion | 2013-03-26 | 2013-03-28 | 674 | — | $0 | 20,975 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion | 2013-03-26 | 2013-03-28 | 2,320 | — | $0 | 20,301 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | C Conversion | 2013-03-26 | 2013-03-28 | 2,320 | — | $0 | 17,981 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2013-03-20 | 2013-03-22 | 5,800 | — | $0 | 5,800 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-01-02 | 2013-01-03 | 16,190 | — | $0 | 16,190 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-10-17 | 2012-10-19 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2012-06-11 | 2012-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2012-01-03 | 2012-01-04 | 9,375 | — | $0 | 9,375 | SEC↗ |